Foetal haemoglobin inducers and thalassaemia: novel achievements.
作者信息
Gambari Roberto
出版信息
Blood Transfus. 2010 Jan;8(1):5-7. doi: 10.2450/2009.0137-09.
Abstract
摘要
相似文献
1
Foetal haemoglobin inducers and thalassaemia: novel achievements.胎儿血红蛋白诱导剂与地中海贫血：新进展
Blood Transfus. 2010 Jan;8(1):5-7. doi: 10.2450/2009.0137-09.
2
High-level induction of fetal haemoglobin by pomalidomide in β-thalassaemia/HbE erythroid progenitor cells.泊马度胺对β地中海贫血/HbE红系祖细胞中胎儿血红蛋白的高水平诱导作用。
Br J Haematol. 2020 Jun;189(6):e240-e245. doi: 10.1111/bjh.16670. Epub 2020 May 2.
3
A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia.一项关于口服胎儿血红蛋白诱导剂HQK-1001治疗中间型β地中海贫血的2期研究。
Br J Haematol. 2014 Feb;164(3):456-8. doi: 10.1111/bjh.12635. Epub 2013 Nov 13.
4
Induction of fetal hemoglobin as a novel therapeutic strategy for β-hemoglobinopathy.诱导胎儿血红蛋白作为β-血红蛋白病的一种新型治疗策略。
Lab Hematol. 2014 Mar 1;20(1):1. doi: 10.1532/LH96.12015.
5
Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy.一名对传统疗法耐药的重型地中海贫血患者对沙利度胺的最佳反应。
Blood Transfus. 2010 Jan;8(1):63-5. doi: 10.2450/2009.0102-09.
6
Compound heterozygous beta thalassaemia and hereditary persistence of foetal haemoglobin presenting as thalassemia intermedia.表现为中间型地中海贫血的复合杂合子β地中海贫血和胎儿血红蛋白遗传性持续存在
Indian J Pathol Microbiol. 2023 Oct-Dec;66(4):888-890. doi: 10.4103/ijpm.ijpm_250_22.
7
Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-β thalassaemia.与输血依赖型 HbE-β 地中海贫血胎儿血红蛋白药物诱导相关的遗传决定因素。
Ann Hematol. 2019 Feb;98(2):289-299. doi: 10.1007/s00277-018-3536-x. Epub 2018 Nov 9.
8
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients.雷帕霉素对β地中海贫血患者红系前体细胞中α、β和γ珠蛋白mRNA积累的影响。
Eur J Haematol. 2006 Nov;77(5):437-41. doi: 10.1111/j.1600-0609.2006.00731.x. Epub 2006 Aug 24.
9
Observations on the high foetal haemoglobin gene and its interaction with the thalassaemia gene.关于高胎儿血红蛋白基因及其与地中海贫血基因相互作用的观察
J Clin Pathol. 1962 Jul;15(4):350-6. doi: 10.1136/jcp.15.4.350.
引用本文的文献
1
Safety and Efficacy of Thalidomide and Hydroxyurea Combination in Beta Thalassemia Patients.沙利度胺与羟基脲联合用药治疗β地中海贫血患者的安全性和有效性
Indian J Hematol Blood Transfus. 2023 Jan;39(1):85-89. doi: 10.1007/s12288-022-01536-y. Epub 2022 Apr 21.
2
MicroRNAs and Long Non-coding RNAs in Genetic Diseases.微小 RNA 和长非编码 RNA 在遗传性疾病中的作用。
Mol Diagn Ther. 2019 Apr;23(2):155-171. doi: 10.1007/s40291-018-0380-6.
3
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.基于基因治疗介导的成人血红蛋白（HbA）生成和胎儿血红蛋白（HbF）诱导的β-地中海贫血联合治疗方法。
Ann Hematol. 2012 Aug;91(8):1201-13. doi: 10.1007/s00277-012-1430-5. Epub 2012 Mar 31.
本文引用的文献
1
Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy.一名对传统疗法耐药的重型地中海贫血患者对沙利度胺的最佳反应。
Blood Transfus. 2010 Jan;8(1):63-5. doi: 10.2450/2009.0102-09.
2
An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project.地中海贫血及其他血红蛋白病研究与治疗的电子基础设施：欧洲-地中海ITHANET项目
Hemoglobin. 2009;33(3):163-76. doi: 10.1080/03630260903089177.
3
Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies.用于治疗血红蛋白病的胎儿血红蛋白化学诱导剂。
Ann Hematol. 2009 Jun;88(6):505-28. doi: 10.1007/s00277-008-0637-y. Epub 2008 Nov 15.
4
Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.天然产物中的胎儿血红蛋白诱导剂：一种用于鉴定治疗β-地中海贫血和镰状细胞贫血药物的新方法。
Evid Based Complement Alternat Med. 2009 Jun;6(2):141-51. doi: 10.1093/ecam/nem139. Epub 2007 Dec 11.
5
Thalidomide therapy in a patient with thalassemia major.一名重型地中海贫血患者的沙利度胺治疗。
Blood Cells Mol Dis. 2008 Jul-Aug;41(1):136-7. doi: 10.1016/j.bcmd.2008.03.001. Epub 2008 Apr 24.
6
A novel frameshift mutation (+A) at codon 18 of the beta-globin gene associated with high persistence of fetal hemoglobin phenotype and deltabeta-thalassemia.β-珠蛋白基因第18密码子处的一种新型移码突变（+A），与胎儿血红蛋白表型的高持续性和δβ地中海贫血相关。
Acta Haematol. 2008;119(1):28-37. doi: 10.1159/000114204. Epub 2008 Jan 30.
7
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells.泊马度胺和来那度胺调节人CD34+细胞中的红细胞生成和胎儿血红蛋白生成。
J Clin Invest. 2008 Jan;118(1):248-58. doi: 10.1172/JCI32322.
8
Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia.用于治疗β地中海贫血的胎儿血红蛋白诱导剂的药物化学
Curr Med Chem. 2007;14(2):199-212. doi: 10.2174/092986707779313318.
9
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients.雷帕霉素对β地中海贫血患者红系前体细胞中α、β和γ珠蛋白mRNA积累的影响。
Eur J Haematol. 2006 Nov;77(5):437-41. doi: 10.1111/j.1600-0609.2006.00731.x. Epub 2006 Aug 24.
10
Progress toward the genetic treatment of the beta-thalassemias.β地中海贫血症基因治疗的进展。
Ann N Y Acad Sci. 2005;1054:78-91. doi: 10.1196/annals.1345.010.
Zotero 插件